Roche has revealed new trial data that make the case for use of its haemophilia A drug Hemlibra in an expanded patient group, ahead of a decision by the FDA in the autumn.
Roche has been hit with another exec departure after it said Roland Diggelmann will leave his role as CEO of its diagnostics division to “pursue his career outside of the company”.
China's national regulator has granted a rapid approval for Roche’s lung cancer treatment Alecensa just months after European and American approvals, following a revamp of the country's not